Valerio Therapeutics S.A.
ALVIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €10,188 | €11,541 | €16,427 | €25,448 |
| - Cash | €2,638 | €1,178 | €4,003 | €6,818 |
| + Debt | €18,570 | €13,435 | €13,222 | €8,998 |
| Enterprise Value | €26,120 | €23,798 | €25,646 | €27,628 |
| Revenue | €126 | €1,704 | €89 | €1,800 |
| % Growth | -92.6% | 1,814.6% | -95.1% | – |
| Gross Profit | -€1,868 | -€2,876 | -€74 | €1,486 |
| % Margin | -1,482.5% | -168.8% | -83.1% | 82.6% |
| EBITDA | -€104 | -€2,963 | -€9,427 | -€7,262 |
| % Margin | -82.5% | -173.9% | -10,592.1% | -403.4% |
| Net Income | -€208 | -€12,973 | -€10,958 | -€8,700 |
| % Margin | -165.1% | -761.3% | -12,312.4% | -483.3% |
| EPS Diluted | -0.001 | -0.084 | -0.067 | -0.056 |
| % Growth | 98.3% | -26.2% | -18.4% | – |
| Operating Cash Flow | -€3,602 | -€5,627 | -€6,833 | -€9,477 |
| Capital Expenditures | -€107 | -€279 | -€40 | -€86 |
| Free Cash Flow | -€3,709 | -€5,906 | -€6,873 | -€9,563 |